Member access

4-Traders Homepage  >  Shares  >  Euronext Paris  >  PCAS    PCA   FR0000053514

PCAS (PCA)

75
End-of-day quote. End-of-day quote BATS EUROPE - 11/30
0.0000 EUR   0.00%
09/04 PCAS : 2014 half-year results
07/30 PCAS : 2014 first-half sales
04/22 PCAS : PCAS: QUARTERLY FINANCIAL INFORMATION As of March 31, 2014
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll news 

PCAS : quarterly financial reporting Sep 30, 2011

10/07/2011 | 11:40am US/Eastern
Recommend:
0

Quarterly financial reporting
As of 30 September 2011

 

 

Business update

 

(in thousands of euros)20112010% change
 First Quarter44,05341,4346,3%
 including Pharmaceutical Synthesis27,14726,6032,0%
 including Specialty Chemicals16,90614,83114,0%
 Second Quarter41,78942,698-2,1%
 including Pharmaceutical Synthesis26,45728,100-5,8%
 including Specialty Chemicals15,33214,5985,0%
 Third Quarter33,48133,658-0,5%
 including Pharmaceutical Synthesis19,53018,3946,2%
 including Specialty Chemicals13,95115,264-8,6%
 Total as of 30 September119,323117,7901,3%
 including Pharmaceutical Synthesis73,13473,0970,1%
 including Specialty Chemicals46,18944,6933,3%

 

 

 

The PCAS Group's consolidated revenues at 30 September 2011came in 1.3% higher than the same period the previous year.

 

Pharmaceutical Synthesis
Over the first five months of the year, business was affected by the planned reduction in the contribution by the new contract between PCAS and Sanofi, effective since 31 May 2010. Excluding this contract, the Exclusive and Non-Exclusive Pharma business is up 10.5% at 30 September 2011.
Fine Specialty Chemicals
With growth of 3.3% at 30 September 2011, the Fine Specialty Chemicals business contracted by 8.6% during the third quarter of 2011 in relation to 2010, reflecting the economic slowdown seen since the summer.

 

Key operations and events for the quarter

 

No important events likely to have a significant impact on the company's business or situation occurred during the third quarter of 2011.

 

Outlook for the current year

 

The high level of sales expected for the fourth quarter should lead to earnings growth in 2011.

 

 

Next date :  2011 earnings, February 22nd, 2012

 

 

About PCAS
PCAS is a fine and specialty chemicals group that shares an ambition for excellence with its customers, which primarily include market-leading international groups. PCAS designs and delivers the best industrial solutions for its customers' specific expectations. These various expectations all share a common demand for safety, quality, competitiveness, innovation and sustainability.

 

Longjumeau, October 7th, 2011

 

PCAS_T3_2011_EN:
http://hugin.info/143512/R/1553112/478624.pdf



This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: PCAS via Thomson Reuters ONE

HUG#1553112
Recommend :
0
React to this article
Latest news on PCAS
09/04 PCAS : 2014 half-year results
07/30 PCAS : 2014 first-half sales
07/16 SK HYNIX : Patent Issued for Domain Crossing Circuit of Semiconductor Apparatus
06/10 PCAS : From Close Air Support To Fire Suppression
06/09 PCAS : 2014/06/09 From Close Air Support to Fire Suppression
04/22 PCAS : PCAS: QUARTERLY FINANCIAL INFORMATION As of March 31, 2014
04/09 PCAS : Glycopyrrolate
04/09 PCAS : CHBD in China & CPHI in Japan
04/08 PCAS : Gycopyrrolate
04/08 PCAS : CHBD in China & CPHI in Japan
Advertisement
Chart
Duration : Period :
PCAS Technical Analysis Chart | PCA | FR0000053514 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF